<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Care Access 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=44162></link><description><![CDATA[Care Access 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sun, 03 May 2026 18:16:21 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2023/10/12_31017998_20231012100045_1782037056.png]]></url></image><language>ko-KR</language><item><title><![CDATA[FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial]]></title><link>https://www.newswire.co.kr/newsRead.php?no=976123</link><description><![CDATA[BOSTON--(Business Wire/Korea Newswire)--Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer VALOR trial. The inspection resulted in no FDA Form 483 observations, meaning the FDA investigator found no GCP violations by Care Access in the VALOR trial. T...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2023/10/31017998_20231012100305_7327270872.jpg]]></url></image><pubDate>Thu, 12 Oct 2023 10:08:56 +0900</pubDate></item></channel></rss>